Early endovascular thrombectomy improves functional outcomes in large infarct ischaemic stroke
1. Patients in the thrombectomy group reported significantly greater improvement, with lower mortality at 90 days versus medical management alone. ...
Tag: acute ischemic stroke
#VisualAbstract: Intravenous thrombolysis plus endovascular treatment may be more efficacious for acute ischemic stroke
1. The 90-day modified Ranking Scale score was comparable for patients in intravenous thrombolysis plus endovascular treatment versus endovascular treatment ...
#VisualAbstract: Butylphthalide is an effective and safe neuroprotective agent for acute ischemic stroke– the BAST trial
1. Butylphthalide is effective — the BAST trial showed that butylphthalide is associated with more favorable functional outcomes compared to ...
Butylphthalide is an effective and safe neuroprotective agent for acute ischemic stroke– the BAST trial
1. Butylphthalide is effective -- the BAST trial showed that butylphthalide is associated with more favorable functional outcomes compared to ...
Dual antiplatelet therapy is noninferior to alteplase for patients with minor nondisabling acute ischemic stroke – the ARAMIS trial
1. The ARAMIS trial revealed that the rate of favourable neurologic function at 90 days was 93.8% among patients assigned ...
Intravenous tenecteplase non-inferior to alteplase for patients with acute ischemic strokes
1. A similar proportion of patients in the alteplase group reported a modified Rankin Scale score of 0-1 compared to ...
#VisualAbstract: Addition of argatroban to intravenous alteplase did not improve neurologic outcomes in patients with acute ischemic stroke
Click here to read this study in NEJM
#VisualAbstract: Intensive blood pressure control post-endovascular thrombectomy after acute ischemic stroke linked with worse clinical outcomes
1. More intensive blood pressure targets were associated with poor functional outcome at 90 days, neurological deterioration, and major disability ...
Intensive blood pressure control post-endovascular thrombectomy after acute ischemic stroke linked with worse clinical outcomes
1. More intensive blood pressure targets were associated with poor functional outcome at 90 days, neurological deterioration, and major disability ...
Asundexian does not reduce the risk of recurrent strokes after non-cardioembolic ischemic stroke
1. The composite of MRI-detected brain infarcts and symptomatic ischemic stroke was comparable across different doses of asundexian and placebo. ...